Stockscreener 앱 받기
19.86
2.16%
0.42
시간 외 거래:
19.86
Xencor Inc 주식(XNCR)의 최신 뉴스
Xencor Inc (XNCR) Income Statement - TradingKey
Xencor Inc (XNCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Xencor Inc (XNCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Xencor Inc (XNCR) Balance Sheet - TradingKey
Xencor Inc (XNCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ETFs Investing in Xencor, Inc. Stocks - TradingView
Xencor, Inc. Revenue Breakdown – DUS:XE9 - TradingView
Xencor Inc (XNCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xencor, Inc. (XNCR) Stock Forecasts - Yahoo! Finance Canada
Xencor (NASDAQ:XNCR) Stock Price Down 6.7%Should You Sell? - MarketBeat
(XNCR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Xencor (NASDAQ:XNCR) Hits A High: Can Momentum Last? - Kalkine Media
Xencor stock hits 52-week high at 18.83 USD - Investing.com India
Xencor (NASDAQ:XNCR) Sets New 52-Week HighShould You Buy? - MarketBeat
Xencor stock hits 52-week high at 18.83 USD By Investing.com - Investing.com South Africa
Xencor (NASDAQ:XNCR) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Xencor (XNCR) Soars 16.9%: Is Further Upside Left in the Stock? - Yahoo Finance
Xencor Shares Kidney Cancer Trial Results at ESMO - t.co
Xencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma - BioSpace
Xencor shows strong pipeline progress with prom... - Pluang
Xencor: Strong Buy, XmAb819 Presentation, And End Of 2026 XmAb942 Interim Data - Seeking Alpha
Xencor (XNCR) Shares Jump 17% Following ESMO 2026 Announcement - GuruFocus
Xencor (NASDAQ:XNCR) Stock Price Up 7.9%What's Next? - MarketBeat
Xencor’s XmAb819 data to be presented at ESMO congress By Investing.com - Investing.com South Africa
Xencor’s XmAb819 data to be presented at ESMO congress - Investing.com
Xencor to present Phase 1 XmAb819 data in advanced kidney cancer at ESMO 2026 - Bitget
Pharmaceutical Method-of-Use Claims After Teva v. Eli Lilly and In re Xencor: Written Description, Enablement, and the Known-Compound Genus - The National Law Review
Xencor: Bullish On Their Increasingly In-House Pipeline (NASDAQ:XNCR) - Seeking Alpha
Xencor (NASDAQ:XNCR) Shares Down 6.6%Should You Sell? - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Xencor Inc. (XNCR) Faces Pressure as Shares Slide Toward Key SupportQuality Factor - dars.gov.et
Form 4 Xencor Inc For: 8 July By Investing.com - Investing.com Nigeria
Ellen Feigal at Xencor (XNCR) receives RSUs and options equity awards - Stock Titan
Xencor (XNCR) awards RSUs and stock options to director Gorman - Stock Titan
Xencor (XNCR) director Kurt Gustafson granted RSUs and stock options - Stock Titan
[Form 4] Xencor Inc Insider Trading Activity - Stock Titan
Xencor (XNCR) director granted RSUs and stock options in equity award - Stock Titan
Xencor (XNCR) director granted RSUs and 20,604 stock options at $12.20 - Stock Titan
Xencor (NASDAQ: XNCR) awards director stock grants vesting within a year - Stock Titan
Xencor (NASDAQ: XNCR) director receives new RSU and stock option grant - Stock Titan
Frontier tech research, news & data - MLQ.ai
Truist Financial Maintains Xencor(XNCR.US) With Buy Rating, Cuts Target Price to $27 - Moomoo
XENCOR Maintains Buy Rating -- Price Target Lowered to $27.00 by Truist Securities - GuruFocus
XNCRXencor Inc Revenue Breakdown - Finviz
Xencor (XNCR) Declines 4.5% as Selling Pressure Builds Near SupportTurnaround Stocks - dars.gov.et
Enterprise value to revenue forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Price to earnings forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Enterprise value to EBIT forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Price to sales forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Price to sales forward of Xencor, Inc. – TRADEGATE:XE9 - TradingView
Xencor (XNCR) Surges Over 6% as Biotech Sector Momentum Drives Shares Toward Key ResistanceInsider Selling Alerts - dars.gov.et
Liquidity Mapping Around (XNCR) Price Events - Stock Traders Daily
XE9 Forecast — Price Target — Prediction for 2027 - TradingView
Xencor, Inc. Actuals & Estimates (FWB:XE9) - TradingView
XNCR Forecast — Price Target — Prediction for 2027 - TradingView
Xencor, Inc. Actuals & Estimates (NASDAQ:XNCR) - TradingView
Price to book forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Xencor Inc (XNCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Xencor director Ellen Feigal sells $89,369 in company stock By Investing.com - Investing.com South Africa
1.97%
0.83%
자본화:
|
볼륨(24시간):